4//SEC Filing
Li Dean Y 4
Accession 0001127602-25-013039
CIK 0000310158other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:04 PM ET
Size
8.6 KB
Accession
0001127602-25-013039
Insider Transaction Report
Form 4
Li Dean Y
Executive VP & President, MRL
Transactions
- Award
Stock Option (Right to Buy)
2025-04-29+64,481→ 64,481 totalExercise: $84.71From: 2026-04-29Exp: 2035-04-28→ Common Stock (64,481 underlying) - Award
Restricted Stock Unit
2025-04-29+14,166→ 14,166 totalFrom: 2026-04-29Exp: 2028-04-29→ Common Stock (14,166 underlying)
Holdings
- 80,180.794
Common Stock
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
- [F4]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001837016
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 6:04 PM ET
- Size
- 8.6 KB